Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System
NCT04337541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6000
Last updated 2020-08-03
Summary
In the current COVID-19 pandemic with coronavirus, SARS-COV2, the Danish Health Authorities recommend using facial masks in the health care system when handling patients presumed or proven to be infected with the virus. However, the use of facial masks outside the health care system is not recommended by the Danish Health Authorities. Here, Health Authorities in other countries have different recommendations for the use of facial masks.
Challenges when using facial masks outside the health care system include wearing the mask consistently, an efficacy of the mask of app. 8 hours necessitating a change of mask throughout the day, and that it is not sufficiently tight enough to safely keep the virus out. Moreover, the eyes (mucous membrane) remain exposed. Compliance could also be another challenge.
SARS-COV2 is assumed to primarily enter the body via the mouth through respiratory droplets - or possibly through inhalation of aerosol containing the virus. From the mouth the virus is assumed to spread to the airways and the gastro-intestinal tract. SARS-COV2 is also known to be transmitted via physical contact, helped along by the fact that the virus can survive on surfaces for at least 72 hours. Touching such a contaminated surface can transfer the virus to the mouth via the hand - and thus lead to infection of the person.
Facial masks are expected to protect against viral infection in two ways;
1. By reducing the risk of getting the virus in via the mouth or nose via respiratory droplets or aerosol
2. By reducing the transfer from virus-contaminated hands to the mouth or nose
Hypothesis The use of surgical facial masks outside the hospital will reduce the frequency of COVID-19 infection.
All participants will follow authority recommendations and be randomized to either wear facial masks or not. The participants will be screened for antibodies at study start and study end. They will perform swab-test if they experience symptoms during the study as well as the end of study.
Conditions
Interventions
- OTHER
-
Surgical facial mask
Participants will follow normal Authority recommendations AND wear mask outside their homes, or when receiving visits in their home.
Sponsors & Collaborators
-
Nordsjaellands Hospital
collaborator OTHER -
Hvidovre University Hospital
collaborator OTHER -
Herlev Hospital
collaborator OTHER -
Technical University of Denmark
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Henrik Ullum, Prof., DMSc · Rigshospitalet, Denmark
-
Kasper Karmark Iversen, Prof., DMSc · Herlev Hospital
-
Thomas Benfield, Prof., DMSc · Hvidovre University Hospital
-
Christian Torp-Pedersen, Prof., DMSc · Nordsjaellands Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-04-02
- Primary Completion
- 2020-06-02
- Completion
- 2020-06-02
Countries
- Denmark
Study Locations
More Related Trials
-
The Respiratory Protection Effectiveness Clinical Trial
NCT01249625 ·Status: COMPLETED ·Phase: NA
-
Seroconversion Among Staff at a Large Acute Care Hospital in Denmark During the COVID-19 Pandemic
NCT04431310 ·Status: UNKNOWN
-
Support for COVID19 Patients at Home
NCT04898179 ·Status: COMPLETED
-
Identifying Functional and Psycho-social Complaints After Hospitalization for SARS-CoV-2 Infection( COVID 19)- REPERCOV
NCT04561154 ·Status: UNKNOWN ·Phase: NA
-
PERSONAL PROTECTION EQUIPMENT AND SARS-CoV-2 CONTAMINATION
NCT05008627 ·Status: COMPLETED
-
Registry of Management Strategies for Patients With COVID-19 in Healthcare Establishments
NCT05069389 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 Infection
NCT05336110 ·Status: COMPLETED
-
Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit
NCT04355481 ·Status: UNKNOWN
-
Comorbidities And Complications Associated With Covid-19 Infection
NCT04563442 ·Status: UNKNOWN
-
Clinical Outcomes of Patients With COVID19
NCT04280913 ·Status: WITHDRAWN
-
Convalescent Plasma Therapy vs. SOC for the Treatment of COVID-19 in Hospitalized Patients
NCT04345523 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients.
NCT04372979 ·Status: TERMINATED ·Phase: PHASE3
-
Rational Use of Personal Protective Equipment During COVID-19 Pandemic
NCT04712045 ·Status: COMPLETED ·Phase: NA
-
Medical Masks vs N95 Respirators for COVID-19
NCT04296643 ·Status: COMPLETED ·Phase: PHASE4
-
Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression.
NCT04374526 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Home-based Care and Hand Hygiene Interventions in Honduras
NCT04886414 ·Status: COMPLETED ·Phase: NA
-
Enhanced Hood PPE to Minimize COVID-19 Transmission to Front-line Health Care Workers
NCT04373096 ·Status: UNKNOWN ·Phase: NA
-
Bacterial Contamination of Healthcare Worker Uniforms
NCT01537835 ·Status: COMPLETED ·Phase: NA
-
Evaluation of ARFC Masks Equipped With CF5 Filter in the Care Unit to Allow a Wider Distribution of FFP2 Masks (Covid-19).
NCT04427176 ·Status: COMPLETED
-
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT04961489 ·Status: COMPLETED
-
NO Prevention of COVID-19 for Healthcare Providers
NCT04312243 ·Status: TERMINATED ·Phase: PHASE2
-
IMPACT STUDY: Investigating Microbial Pathogen Activity of Copper Textiles
NCT02627092 ·Status: COMPLETED ·Phase: NA
-
Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
NCT04279782 ·Status: UNKNOWN
-
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes
NCT06285838 ·Status: COMPLETED
-
Early Mobilization of Patients With Community-acquired Pneumonia
NCT03426813 ·Status: COMPLETED ·Phase: NA